Neuronetics Announces Lisa Metzner-Rosas as SVP, Chief Marketing Officer
May 01, 2023 08:46 ET
|
Neuronetics
MALVERN, Pa., May 01, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Announces Expanded TMS Access through United HealthCare
April 28, 2023 16:11 ET
|
Neuronetics
MALVERN, Pa., April 28, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics to Report First Quarter 2023 Financial and Operating Results and Host Conference Call
April 25, 2023 08:30 ET
|
Neuronetics
MALVERN, Pa., April 25, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Announces Continued Momentum for Expanded Health Insurance Coverage for TMS Therapy
April 13, 2023 08:58 ET
|
Neuronetics
MALVERN, Pa., April 13, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
NeuroStar® Advanced Therapy Enhanced With Wi-Fi Capabilities
April 06, 2023 16:16 ET
|
Neuronetics
MALVERN, Pa., April 06, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Secures Up To $60 Million in New Debt Financing with SLR Capital Partners, Provides Greenbrook TMS with $6.0 Million Promissory Note
April 04, 2023 08:30 ET
|
Neuronetics
MALVERN, Pa., April 04, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients...
NeuroStar® Advanced Therapy Receives Patient Impact Award from Life Sciences PA
March 16, 2023 08:56 ET
|
Neuronetics
MALVERN, Pa., March 16, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Reports Record Fourth Quarter and Record Full Year 2022 Financial and Operating Results
March 07, 2023 07:30 ET
|
Neuronetics
MALVERN, Pa., March 07, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients...
Neuronetics Announces TMS Coverage Criteria Changes for Over 23 Million Covered Lives
March 02, 2023 16:02 ET
|
Neuronetics
MALVERN, Pa., March 02, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 27, 2023 16:30 ET
|
Neuronetics
MALVERN, Pa., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...